aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.

You May Also Be Interested In

• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• Youdao, Inc. (DAO) Tops Q2 EPS by 50c
• BofA Securities Upgrades Etsy (ETSY) to Buy, 'Still Room to Run'